BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients
Stopped Phase I was conducted Australia. Phase II not conducted and no US pts enrolled.
Conditions
Interventions
- DRUG: Carboplatin
- DRUG: Gemcitabine
- DRUG: Carboplatin
- DRUG: Gemcitabine
- DRUG: BNC105P
Sponsor
Hoosier Cancer Research Network
Collaborators
- [object Object]
- [object Object]
- [object Object]